Assignee
INOZYME PHARMA INC
US·3 granted patents·15 pending applications·2 citations·filing 2015–2025
Top patents by PatentIndex Score
18 records- 0180US2023129977A1Npp1 fusion proteinsINOZYME PHARMA INC·Filed 2022·Application pending·0 cites
- 0280US2026022356A1NPP1 Fusion ProteinsINOZYME PHARMA INC·Filed 2025·Application pending·0 cites
- 0374US11364284B2Methods of treating myointimal proliferationINOZYME PHARMA INC·Filed 2017·Granted Jun 21, 2022·2 cites·18 claims
- 0474US2025019677A1Methods of improving cardiovascular function and treating cardiovascular disease using a recombinant ectonucleotide pyrophosphatase phosphodiesterase (npp1)INOZYME PHARMA INC·Filed 2024·Application pending·0 cites
- 0573US2021301268A1Npp1 fusion proteinsINOZYME PHARMA INC·Filed 2020·Application pending·0 cites
- 0668US2023031809A1Treatment of diseases involving deficiency of enpp1 or enpp3INOZYME PHARMA INC·Filed 2022·Application pending·0 cites
- 0767US2025073319A1Lyophilized enpp1 polypeptide formulations and uses thereofINOZYME PHARMA INC·Filed 2024·Application pending·0 cites
- 0865US2025170223A1Treatment of enpp1 deficiency and abcc6 deficiencyINOZYME PHARMA INC·Filed 2024·Application pending·0 cites
- 0960US12134790B2Methods of improving cardiovascular function and treating cardiovascular disease using a recombinant ectonucleotide pyrophosphatase phosphodiesterase (NPP1)INOZYME PHARMA INC·Filed 2018·Granted Nov 5, 2024·0 cites·25 claims
- 1060US2021187067A1Treatment of diseases involving deficiency of enpp1 or enpp3INOZYME PHARMA INC·Filed 2021·Application pending·0 cites
- 1160US2024148907A1Liver specific production of enpp1 or enpp3INOZYME PHARMA INC·Filed 2023·Application pending·0 cites
- 1257US2022354933A1Methods of treating myointimal proliferationINOZYME PHARMA INC·Filed 2022·Application pending·0 cites
- 1357US2024181021A1Treatment of ENPP1 Deficiency and ABCC6 DeficiencyINOZYME PHARMA INC·Filed 2023·Application pending·0 cites
- 1456US2023313158A1Soluble enpp1 proteins and uses thereofINOZYME PHARMA INC·Filed 2022·Application pending·0 cites
- 1552US2023330307A1Compositions and methods for inhibiting vascular smooth muscle cell proliferationINOZYME PHARMA INC·Filed 2022·Application pending·0 cites
- 1650US2023372455A1Compositions and methods for treating peripheral artery diseaseINOZYME PHARMA INC·Filed 2022·Application pending·0 cites
- 1748US2024016951A1Compositions and methods for treating allograft vasculopathy, moyamoya disease, moyamoya syndrome and intimal proliferationINOZYME PHARMA INC·Filed 2022·Application pending·0 cites
- 1846USRE49529EMethods of treating tissue calcificationINOZYME PHARMA INC·Filed 2015·Granted May 16, 2023·0 cites·29 claims
Join the waitlist — get patent alerts
Get an alert when INOZYME PHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →